These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 31461880)

  • 1. The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma.
    Fields GB
    Cells; 2019 Aug; 8(9):. PubMed ID: 31461880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there new hope for therapeutic matrix metalloproteinase inhibition?
    Vandenbroucke RE; Libert C
    Nat Rev Drug Discov; 2014 Dec; 13(12):904-27. PubMed ID: 25376097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of Action of Novel Drugs Targeting Angiogenesis-Promoting Matrix Metalloproteinases.
    Fields GB
    Front Immunol; 2019; 10():1278. PubMed ID: 31214203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase inhibition by heterotrimeric triple-helical Peptide transition state analogues.
    Bhowmick M; Stawikowska R; Tokmina-Roszyk D; Fields GB
    Chembiochem; 2015 May; 16(7):1084-92. PubMed ID: 25766890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors.
    Hurst DR; Schwartz MA; Jin Y; Ghaffari MA; Kozarekar P; Cao J; Sang QX
    Biochem J; 2005 Dec; 392(Pt 3):527-36. PubMed ID: 16026329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marine pharmacology: therapeutic targeting of matrix metalloproteinases in neuroinflammation.
    Gentile E; Liuzzi GM
    Drug Discov Today; 2017 Feb; 22(2):299-313. PubMed ID: 27697495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution.
    Arkadash V; Yosef G; Shirian J; Cohen I; Horev Y; Grossman M; Sagi I; Radisky ES; Shifman JM; Papo N
    J Biol Chem; 2017 Feb; 292(8):3481-3495. PubMed ID: 28087697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the variability of the S1' pocket to improve matrix metalloproteinase inhibitor selectivity profiles.
    Gimeno A; Beltrán-Debón R; Mulero M; Pujadas G; Garcia-Vallvé S
    Drug Discov Today; 2020 Jan; 25(1):38-57. PubMed ID: 31513929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors.
    Skiles JW; Gonnella NC; Jeng AY
    Curr Med Chem; 2004 Nov; 11(22):2911-77. PubMed ID: 15544483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.
    Liu J; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 148():355-420. PubMed ID: 28662828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview.
    Mondal S; Adhikari N; Banerjee S; Amin SA; Jha T
    Eur J Med Chem; 2020 May; 194():112260. PubMed ID: 32224379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent opportunities in matrix metalloproteinase inhibitor drug design for cancer.
    Zhong Y; Lu YT; Sun Y; Shi ZH; Li NG; Tang YP; Duan JA
    Expert Opin Drug Discov; 2018 Jan; 13(1):75-87. PubMed ID: 29088927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Roles of Matrix Metalloproteinases in Pancreatic Cancer.
    Knapinska AM; Estrada CA; Fields GB
    Prog Mol Biol Transl Sci; 2017; 148():339-354. PubMed ID: 28662827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective function-blocking monoclonal human antibody highlights the important role of membrane type-1 matrix metalloproteinase (MT1-MMP) in metastasis.
    Remacle AG; Cieplak P; Nam DH; Shiryaev SA; Ge X; Strongin AY
    Oncotarget; 2017 Jan; 8(2):2781-2799. PubMed ID: 27835863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix Metalloproteinase Triple-Helical Peptide Inhibitors: Potential Cross-Reactivity with Caspase-11.
    Knapinska AM; Hart M; Drotleff G; Fields GB
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31795279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of Matrix Metalloproteinase-9 (MMP-9) as a Novel Target for Treatment of Diabetic Foot Ulcers in Humans and Discovery of a Potent and Selective Small-Molecule MMP-9 Inhibitor That Accelerates Healing.
    Nguyen TT; Ding D; Wolter WR; Pérez RL; Champion MM; Mahasenan KV; Hesek D; Lee M; Schroeder VA; Jones JI; Lastochkin E; Rose MK; Peterson CE; Suckow MA; Mobashery S; Chang M
    J Med Chem; 2018 Oct; 61(19):8825-8837. PubMed ID: 30212201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment.
    Rashid ZA; Bardaweel SK
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.
    Tauro M; Laghezza A; Loiodice F; Agamennone M; Campestre C; Tortorella P
    Bioorg Med Chem; 2013 Nov; 21(21):6456-65. PubMed ID: 24071448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?
    Creemers EE; Cleutjens JP; Smits JF; Daemen MJ
    Circ Res; 2001 Aug; 89(3):201-10. PubMed ID: 11485970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The design, structure, and therapeutic application of matrix metalloproteinase inhibitors.
    Skiles JW; Gonnella NC; Jeng AY
    Curr Med Chem; 2001 Mar; 8(4):425-74. PubMed ID: 11172697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.